MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

07 Nov 2023 Evaluate
A slight decline in the revenue of Rs. 21593.00 millions was seen for the September 2023 quarter as against Rs. 22618.00 millions during year-ago period.Handsome Net Profit growth of 78.45% reported above the corresponding previous quarter figure of Rs. 8050.00 millions to Rs. 4511.00 millions.OP of the company witnessed a marginal growth to 11839.00 millions from 7882.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 21593.00 22618.00 -4.53 51150.00 41393.00 23.57 87316.00 78369.00 11.42
Other Income 6212.00 2462.00 152.32 7036.00 4013.00 75.33 5484.00 1787.00 206.88
PBIDT 11839.00 7882.00 50.20 24073.00 13842.00 73.91 30028.00 20968.00 43.21
Interest 909.00 641.00 41.81 1806.00 1047.00 72.49 2782.00 1349.00 106.23
PBDT 10930.00 7241.00 50.95 22267.00 12795.00 74.03 25208.00 16426.00 53.46
Depreciation 1249.00 1240.00 0.73 2461.00 2471.00 -0.40 4886.00 4787.00 2.07
PBT 9681.00 6001.00 61.32 19806.00 10324.00 91.84 20322.00 11639.00 74.60
TAX 1631.00 1490.00 9.46 3947.00 2498.00 58.01 5030.00 3060.00 64.38
Deferred Tax -85.00 44.00 -293.18 -133.00 38.00 -450.00 412.00 458.00 -10.04
PAT 8050.00 4511.00 78.45 15859.00 7826.00 102.65 15292.00 8579.00 78.25
Equity 1012.00 1012.00 0.00 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 54.83 34.85 57.33 47.06 33.44 40.74 34.39 26.76 28.53
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..